[{"address1": "302, 6 Butler Street", "city": "Camberwell", "state": "VIC", "zip": "3124", "country": "Australia", "phone": "61 3 9882 0780", "fax": "61 3 9882 9969", "website": "https://www.propanc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Ja\u00e9n that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Ja\u00e9n and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Mr. James  Nathanielsz", "age": 49, "title": "Executive Chairman, CEO, CFO, Treasurer & Secretary", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 430284, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Julian Norman Kenyon ChB, M.D., MB", "age": 75, "title": "Chief Scientific Officer, CTO & Director", "yearBorn": 1948, "fiscalYear": 2023, "totalPay": 35986, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Klaus  Kutz", "title": "Chief Medical Officer & Member of Scientific Advisory Board", "fiscalYear": 2023, "totalPay": 18229, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.002975, "open": 0.0032, "dayLow": 0.003, "dayHigh": 0.0044, "regularMarketPreviousClose": 0.002975, "regularMarketOpen": 0.0032, "regularMarketDayLow": 0.003, "regularMarketDayHigh": 0.0044, "beta": 1.664, "trailingPE": 0.017916668, "volume": 2066861, "regularMarketVolume": 2066861, "averageVolume": 2167338, "averageVolume10days": 3266540, "averageDailyVolume10Day": 3266540, "marketCap": 224223, "fiftyTwoWeekLow": 0.0001, "fiftyTwoWeekHigh": 0.2625, "fiftyDayAverage": 0.00715, "twoHundredDayAverage": 0.0333525, "currency": "USD", "enterpriseValue": 1170483, "floatShares": 52129826, "sharesOutstanding": 52144900, "heldPercentInsiders": 0.013780001, "impliedSharesOutstanding": 52145000, "bookValue": -0.099, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -2727979, "trailingEps": 0.24, "lastSplitFactor": "1:1000", "lastSplitDate": 1605744000, "enterpriseToEbitda": -0.807, "52WeekChange": 3.2857141, "SandP52WeekChange": 0.3219322, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "PPCB", "underlyingSymbol": "PPCB", "shortName": "PROPANC BIOPHARMA INC", "longName": "Propanc Biopharma, Inc.", "firstTradeDateEpochUtc": 1357569000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "a0107681-d11b-3d55-848c-6955d8e78657", "messageBoardId": "finmb_134729532", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.0043, "recommendationKey": "none", "totalCash": 71650, "totalCashPerShare": 0.001, "ebitda": -1450076, "totalDebt": 1017910, "quickRatio": 0.02, "currentRatio": 0.056, "returnOnAssets": -5.18355, "freeCashflow": -436387, "operatingCashflow": -943051, "financialCurrency": "USD", "trailingPegRatio": null}]